This paper investigates the incorporation of intravenously (i.v.) administered radiolabelled fatty acids—[9, 10-3H]palmitate (3H-PA), [1-14C]arachidonate (14C-AA) and [1-14C]docosahexaenoate (14C-DHA)—into intracerebrally implanted tumours in awake Fischer-344 rats. A suspension of Walker 256 carcinosarcoma tumour cells (1 × 106 cells) was implanted into the right cerebral hemisphere of 8- to 9-week-old rats. Seven days after implantation, the awake rat was infused i.v. for 5 min with 3H-PA (6.4 mCi/kg), 14C-AA (170 µCi/kg) or 14C-DHA (100 µCi/kg). Twenty minutes after the start of infusion, the rat was killed and coronal brain sections were obtained for quantitative autoradiography and histology. Each fatty acid showed well-demarcated incorporation into tumour tissue. Areas of necrosis or haemorrhage showed no or small levels of incorporation. The ratios of incorporation into the tumour to incorporation into contralateral brain regions were 2.8–5.5 for 3H-PA, 2.1–3.3 for 14C-AA and 1.5–2.2 for 14C-DHA. The mean ratios differed significantly between the fatty acids (p < 0.01). 3H-PA was not incorporated into necrotic tumours despite the presence of an open blood-tumour barrier, indicated by extravasated horseradish peroxidase. The incorporation rate constant of 3H-PA was similar for small intracerebral and large extracerebral tumours. The results show that 3H-PA, 14C-AA and 14C-DHA. are incorporated more readily into tumour tissue than into brain, and that the increase is primarily due to increased utilization of fatty acids by tumour cells and not due to a high blood-tumour permeability. The relative increases in rates of incorporation for the different fatty acids may be related to lipid composition of the tumour and to the requirement of and specific role of these fatty acids in tumour cell growth and division.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Greig NH, Ries LG, Yanncik R and Rapoport SI, 1990, Increasing annual incidence of primary brain tumours in the elderly: an epidemiological study. Journal of the National Cancer Institute, 20, 1621–1624.
Posner J, 1977, Management of central nervous system metastases. Seminars on Oncology, 4, 81–89.
Greig NH. Brain tumours and the blood-tumour barrier. In: Neuwelt E, ed. Implications of the Blood-Brain Barrier and its Manipulation, Vol. 2, Clinical Studies, pp. 77–106. New York: Plenum Press, 1989.
Greig NH, 1987, Optimizing drug delivery to brain tumours. Cancer Treatment Reviews, 14, 1–28.
Walker M, 1977, Treatment of brain tumours. Medical Clinics of North America, 61, 1045–1051.
Greig NH, 1984, Chemotherapy of brain metastases: current status. Cancer Treatment Reviews, 11, 157–186.
Greig NH, Nariai T, Noronha JG, Schmall B, Larson DM, Soncrant TT and Rapoport SI, 1991, Brain tumour imaging in rats using positron emitting fatty acid radionuclide dl-erythro-9, 10-[18F]-difluoropalmitate. Clinical & Experimental Metastasis, 9, 77–84.
Kimes AS, Sweeney DJ, London ED and Rapoport SI, 1983, Palmitate incorporation into different brain regions in the awake rat. Brain Research, 274, 291–301.
Noronha JG, Bell JM and Rapoport SI, 1990, Quantitative brain autoradiography of [9, 10-3H]palmitic acid incorporation into brain lipids. Journal of Neuroscience Research, 26, 196–208.
DeGeorge JJ, Noronha JG, Bell J, Robinson PJ and Rapoport SI, 1989, Intravenous injection of [1-14C]arachidonate to examine regional brain lipid metabolism in unanaesthetized rats. Journal of Neuroscience Research, 24, 413–423.
Robinson PJ and Rapoport SI, 1989, A method for examining turnover and synthesis of palmitatecontaining brain lipids in vivo. Clinical and Experimental Pharmacology, Phys., 16, 701–714.
Tabata H, Kimes AS, Robinson PJ and Rapoport SI, 1988, Stability of brain incorporation of plasma palmitate in unanaesthetized rats of different ages, with appendix on plamitate model. Experimental Neurology, 102, 221–229.
Robinson PJ, Noronha J, DeGeorge JJ, Nariai T, Rapoport SI and Freed LM, 1992, A quantitative method for measuring regional in vivo fatty acid incorporation into, and turnover within brain phospholipids: review and critical analysis. Brain Research Reviews, 17, 187–214.
Christensen-Lou HO, Clausen J and Bierring F, 1965, Phospholipids and glycolipids of tumours in the central nervous system. Journal of Neurochemistry, 12, 619–627.
Hattori T, Andoh T, Sakaki N, Yamada H, Kameyama Y, Onki K and Nozawa Y, 1987, Membrane phospholipid composition and membrane fluidity of human brain tumours: a spin label study. Neurology Research, 9, 38–43.
Nayyar SN, 1963, A study of phosphate, deoxyribonucleic acid, and phospholipid fraction in neural tumours. Neurology, 13, 287–291.
Yates AJ, Thompson DK and Boesel CP, 1979, Lipid composition of human neural tumours. Journal of Lipid Research, 20, 428–436.
Gopal K, Grossi E and Paoletti P, 1963, Lipid composition of human intracranial tumours. A biochemical study. Acta Neurochirurgica, 11, 333–347.
Montaudon D, Louis JC and Robert J, 1981, Phospholipid acyl group composition in normal and tumour nerve cells in culture. Lipids, 16, 293–297.
Slagel DE, Dittmer JC and Wilson CB, 1967, Lipid composition of human glial tumour and adjacent brain. Journal of Neurochemistry, 14, 789–798.
Sun GY and Leung BS, 1974, Phospholipid and acyl group of subcellular membrane fraction from human intracranial tumours. Journal of Lipid Research, 15, 423–431.
Castelli MG, Butti G, Chiabrando C, Cozzi E, Fanelli R, Gaetani P, Silvani V and Paoletti P, 1987, Arachidonic acid metabolic profiles in human me ningiomas and gliomas. Journal of Neuro-Oncology, 5, 369–375.
Daniel LW, Kucera LS and Waite M, 1980, Metabolism of fatty acids by cultured tumours cells and their diploid precursor fibroblasts. Journal of Biological Chemistry, 255, 5697–5702.
Robert J, Montaudon D and Hughes P, 1983, Incorporation and metabolism of exogenous fatty acids by cultured normal and tumoural glial cells. Biochimica et Biophysica Acta, 752, 383–395.
Nariai T, DeGeorge JJ, Greig NH and Rapoport SI, 1991, In vivo incorporation of [9, 10-3H]palmitate into a rat metastatic brain tumour model. Journal of Neurosurgery, 74, 643–649.
Greig NH, Jones H and Cavanagh J, 1983, Bloodbrain barrier integrity and host responses in experimental metastatic brain tumours. Clinical & Experimental Metastasis, 1, 229–246.
Hanker JS, Yates PE, Metz CB and Rustioni A, 1977, A new specific, sensitive and non-carcinogenic reagent for the demonstration of horseradish peroxidase. Histochemical Journal, 9, 789–792.
Geary II WA, Toga AW and Wooten GF, 1985, Quantitative film autoradiography for tritium: methodological considerations. Brain Research, 337, 99–108.
Tserng K-Y, Kliegman RM, Miettinen E-L and Kalhan SC, 1981, A rapid, simple and sensitive procedure for determination of free fatty acids in plasma using capillary column gas-liquid chromatography. Journal of Lipid Research, 22, 852–858.
Dunnett CW, 1964, New tables for multiple comparisons with a control. Biometrics, 20, 482–491.
Miller R. Simultaneous Statistical Inferences. New York: McGraw-Hill, 1966.
Rapoport SI. Blood-Brain Barrier in Physiology and Medicine, New York: Raven Press.
Albert DH and Anderson CE, 1977, Fatty acid composition of the 2-position of ether-linked and diacyl ethanolamine and choline phosphoglycerides of human brain tumours. Lipids, 12, 722–728.
Murphy S, Jeremy J, Pearce BR and Dandona P, 1985, Eicosanoid synthesis and release from primary cultures of rat CNS astrocytes and meningeal cells. Neuroscience Letters, 61, 61–65.
Piomeli D, Volterra A, Dale N, Siegelbaum SA, Kadel ER, Schwartz JH and Belardetti F, 1987, Lipoxygenase metabolites of arachidonic acid as second messengers for presynaptic inhibition of Aplysia sensory cells. Nature, 328, 38–43.
Cotman C, Blank ML, Moehl A and Snyder F, 1969, Lipid composition of synaptic plasma membranes isolated from rat brain by zonal centrifugation. Biochemistry, 8, 4606–4612.
Lapetina EG, Soto EF and DeRobertis E, 1968, Lipid and proteolipids in isolated subcellular membranes of rat brain cortex. Journal of Neurochemistry, 15, 437–445.
Kaplan J and Moscowitz M, 1975, Studies on the turnover of plasma membranes in cultured mammalian cells: I. Rates of synthesis and degradation of plasma membrane proteins and carbohydrates. Biochimica et Biophysica Acta, 389, 290–305.
Pasternak CA and Bergeron JJM, 1970, Turnover of mammalian phospholipids: stable and unstable components on neoplastic mast cells. Biochemistry Journal, 119, 473–480.
Warren L, 1969, The biological significance of turnover of the surface membrane of animal cells. Current Topics in Developmental Biology, 4, 197–222.
Blasberg RG, Shapiro WR, Molnar P, Patlak CS and Fenstermacher JD, 1984, Local blood to tissue transport in Walker 256 metastatic brain tumours. Journal of Neuro-Oncology, 2, 205–218.
DiChiro G, Oldfield E, Wright DC, Katz DA, Patronas NJ, Doppman JL, Larson SM, Ito M and Kufta CV, 1988, Cerebral necrosis after radio therapy and/or intracranial chemotherapy for brain tumours: PET and neuropathologic studies. American Journal of Radiology, 150, 189–197.
Dooms GC, Hecht S, Brant-Zawadzki M, Berthiaume Y, Norman D and Newton TH, 1986, Brain radiation lesions: MR imaging. Radiology, 158, 149–155.
Tyler JL, Diksic M, Viilemure JG, Evans AC, Meyer E, Yamamoto YL and Feindel W, 1987, Metabolism and hemodynamic evaluation of gliomas using positron emission tomography. Journal of Nuclear Medicine, 28, 1123–1133.
Naito M, Kudo I, Nakagawa Y, Waku K, Nojiri M, Saito M and Inoue K, 1987, Lipids of human promyelocytic leukemia cell HL-60: increasing levels of ether-linked phospholipids during retinoic acid-induced differentiation. Journal of Biochemistry, 102, 155–162.
Gulaya NM, Volkov GL, Klimashevsky B, Govseeva MN and Melnik AA, 1989, Changes in lipid composition of neuroblastoma C1300 N18 cells during differentiation. Neuroscience, 30, 153–164.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nariai, T., Greig, N.H., DeGeorge, J.J. et al. Intravenously injected radiolabelled fatty acids image brain tumour phospholipids in vivo: differential uptakes of palmitate, arachidonate and docosahexaenoate. Clin Exp Metast 11, 141–149 (1993). https://doi.org/10.1007/BF00114972
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00114972